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Introduction
Mitochondria generate cellular energy in the form of ATP through 
oxidative phosphorylation (OXPHOS). During this process, 
four multiprotein complexes located in the inner mitochondrial 
membrane transfer electrons in a series of redox reactions that 
creates a proton electrochemical gradient across the membrane. 
Complex V (ATP synthase or F0F1-ATPase) is a fifth multisub-
unit complex, which generates ATP using the energy created by 
the proton electrochemical gradient. ATP synthesis and hydro-
lysis by complex V is a sophisticated process that depends on 
the coordinated expression of nuclear and mitochondrial genes 
and the assembly and function of several subunits as an active 
complex. As a result of the centrality of mitochondrial energy 
generation in all vital cellular functions, impairment of this pro-
cess in the mitochondria is strongly associated with aging and 
pathology in neurodegenerative disorders, cardiovascular dis-
eases, diabetes, and cancer (Wallace, 2005).
Protein acetylation is emerging as a major posttransla-
tional modification, and it involves reversible acetylation of the 
-amino group of internal lysine residues, which is regulated by 
lysine acetyltransferases and lysine deacetylases (Kouzarides, 
2000; Yang, 2004). In recent years, the class III histone deacety-
lases, the sirtuins, have emerged as prominent deacetylases 
(Haigis and Sinclair, 2010; Zhao et al., 2010; Lombard et al., 
2011; Newman et al., 2012; Xiong and Guan, 2012). Mammals 
contain seven sirtuins: SIRT1, SIRT6, and SIRT7 are nuclear; 
SIRT2 is predominantly cytoplasmic; and SIRT3, SIRT4, and 
SIRT5 localize to the mitochondria. There are five sirtuins in 
Drosophila melanogaster—Sir2 (CG5216), Sirt2 (CG5085), 
Sirt4 (CG3187), Sirt6 (CG6284), and Sirt7 (CG11305). BLAST 
(Basic Local Alignment Search Tool) searches reveal that Dro-
sophila Sir2 shares 42% sequence identity with human SIR2, 
dSirt2 shows 49% identity to SIRT2 and 50% identity to human 
SIRT3, dSirt4 shares 49% identity with human SIRT4, dSirt6 
Adenosine triphosphate (ATP) synthase , the cat-alytic subunit of mitochondrial complex V, syn-thesizes ATP. We show that ATP synthase  is 
deacetylated by a human nicotinamide adenine dinucle-
otide (NAD+)–dependent protein deacetylase, sirtuin 3, 
and its Drosophila melanogaster homologue, dSirt2. 
dsirt2 mutant flies displayed increased acetylation of 
specific Lys residues in ATP synthase  and decreased 
complex V activity. Overexpression of dSirt2 increased 
complex V activity. Substitution of Lys 259 and Lys 480 
with Arg in human ATP synthase , mimicking deacety-
lation, increased complex V activity, whereas substitution 
with Gln, mimicking acetylation, decreased activity. Mass 
spectrometry and proteomic experiments from wild-
type and dsirt2 mitochondria identified the Drosophila  
mitochondrial acetylome and revealed dSirt2 as an im-
portant regulator of mitochondrial energy metabolism. 
Additionally, we unravel a ceramide–NAD+–sirtuin axis 
wherein increased ceramide, a sphingolipid known to 
induce stress responses, resulted in depletion of NAD+ 
and consequent decrease in sirtuin activity. These results 
provide insight into sirtuin-mediated regulation of com-
plex V and reveal a novel link between ceramide and 
Drosophila acetylome.
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In this study, we also reveal a novel connection between 
NAD metabolism, sirtuins, and the sphingolipid ceramide. Sphin-
golipids are an essential class of lipids that are building blocks 
for membranes and serve as transducers in signaling cascades 
that regulate cell growth and death (Hannun and Obeid, 2008). 
Ceramide, a central intermediate in sphingolipid metabolism, 
mediates many stress responses, and recent literature highlights 
that perturbations in ceramide levels can affect glucose and fat 
metabolism (Bikman and Summers, 2011). How ceramide and 
other sphingolipids affect cellular metabolism, what metabolic 
pathways they impinge on, and identification of the ensuing 
functional consequences are only beginning to be explored. 
We show that Drosophila mutants of sphingolipid metabolism, 
particularly, ceramide kinase mutants (dcerk1), have increased 
levels of ceramide and decreased levels of NAD+. This results in 
reduced dSirt2 activity in dcerk1 mutants, leading to acetylation 
of several subunits of complex V, including ATP synthase  and 
reduced complex V activity. These experiments reveal a novel 
axis involving ceramide, NAD, and sirtuins.
Results
Ceramide increase affects NAD+ level  
and sirtuin activity
We performed metabolomic profiling on sphingolipid mutants 
that accumulate ceramide to gain insight into metabolic path-
ways that could be altered in these mutants. Our earlier study 
combined metabolomic profiling with genetic and biochemical 
approaches and demonstrated that dcerk1 mutants show an in-
creased reliance on glycolysis, which leads to an increase in lac-
tate to compensate for the decreased production of ATP through 
OXPHOS (Nirala et al., 2013). The increase in glycolytic flux 
is also observed in a mammalian model of ceramide increase, 
mice heterozygous for the ceramide transfer protein (Wang 
et al., 2009; Nirala et al., 2013). In addition to changes in glyco-
lytic intermediates, metabolomic profiling revealed that dcerk1 
mutants have a significantly decreased level of NAD+ compared 
with that in w1118 (control) flies (Fig. 1 A). The NAD+ level is 
controlled by balancing synthesis, salvage, and consumption 
pathways (Fig. 1 B). Like in mammals, NAD+ can be synthe-
sized in Drosophila from the salvage pathway from nicotinic 
acid, nicotinamide, and nicotinamide riboside (nicotinamide 
mononucleotide) and by the de novo pathway from tryptophan 
(Zhai et al., 2006; Campesan et al., 2011). We used mass spec-
trometry (MS) to measure the levels of intermediates in these 
pathways and related metabolites. The levels of key intermedi-
ates, such as nicotinamide riboside in the salvage pathway and 
hydroxykynurenine in the de novo pathway, of NAD+ synthesis 
in dcerk1 are increased compared with those in controls, sug-
gesting that synthesis pathways do not appear to be compro-
mised (Fig. 1 C). We then tested whether the NAD+ level is 
altered in the ceramidase mutant (cdase1), another mutant of the 
sphingolipid pathway that accumulates ceramide (Acharya et al., 
2008). The NAD+ level is also decreased in cdase1 (Fig. S1). 
Estimation of intermediates of the salvage and de novo path-
ways of NAD+ synthesis in cdase1 reveals a fivefold increase in 
3-hydroxy kynurenine, which suggests a compensatory increase 
shows 50% identity to human SIRT6, and dSirt7 shows 46% 
identity to human SIRT7. dSir2 is the most well characterized 
among the Drosophila sirtuins. It is an essential gene that is ex-
pressed during development, and its localization is thought to 
be both cytoplasmic and nuclear. Sir2 is required for heterochro-
matic gene silencing and euchromatic repression (Rosenberg and 
Parkhurst, 2002). Earlier studies have also demonstrated roles 
for Drosophila Sir2 in life span extension and regulation of cell 
death and survival (Wood et al., 2004; Griswold et al., 2008; 
Banerjee et al., 2012). Sir2 has also been identified as a negative 
regulator of fat storage in Drosophila larvae (Reis et al., 2010). 
A neuroprotective role has been suggested for Sirt2 because its 
loss leads to rescue of photoreceptor death observed in Dro-
sophila models of Huntington’s disease (Luthi-Carter et al., 
2010). Sirtuin activity depends on NAD+, which suggests that 
their activity is linked to the energy status of the cell via the 
NAD+/NADH ratio (Imai et al., 2000; Houtkooper et al., 2010; 
Imai and Guarente, 2010).
Global proteomic surveys have shown that mitochondrial 
proteins are extensively modified by lysine acetylation (Kim 
et al., 2006; Lombard et al., 2007; Choudhary et al., 2009; 
Hebert et al., 2013; Rardin et al., 2013). SIRT3 appears to be 
the major mitochondrial deacetylase. SIRT3-deficient mice 
exhibit mitochondrial protein hyperacetylation, whereas no 
significant changes were observed in SIRT4/ and SIRT5/ 
mitochondria. Despite the increased acetylation of proteins, 
germline deletion of SIRT3 or deletion of SIRT3 in a muscle- 
or liver-specific manner does not result in overt metabolic 
phenotypes (Lombard et al., 2007; Fernandez-Marcos et al., 
2012). However, under conditions of stress such as fasting or 
caloric restriction, SIRT3 has been shown to regulate fatty 
acid oxidation by activating long chain acyl-CoA (coenzyme A) 
dehydrogenase, ketone body production through 3-hydroxy- 
3-methylglutaryl CoA synthase 2, in mitigating reactive 
oxygen species (ROS) damage by deacetylating superoxide 
dismutase, and protecting mice from age-related hearing loss 
through activation of isocitrate dehydrogenase (Hirschey et al., 
2010; Qiu et al., 2010; Shimazu et al., 2010; Someya et al., 
2010; Tao et al., 2010; Chen et al., 2011). A role for SIRT3 
has been implicated in regulating OXPHOS because germline 
Sirt3/ mice show a decrease in ATP levels in different or-
gans (Ahn et al., 2008; Cimen et al., 2010; Finley et al., 2011b; 
Shinmura et al., 2011; Wu et al., 2013). However, muscle- or 
liver-specific deletion of SIRT3 did not result in changes in 
ATP levels, suggesting that SIRT3 deletion in a tissue-specific 
manner does not affect cellular energy levels (Fernandez-Marcos 
et al., 2012). In this study, we have used Drosophila as a model 
and performed mass spectrometric analyses on wild-type and 
dsirt2 mutant flies to identify the Drosophila mitochondrial 
and dSirt2-regulated acetylome. Our proteomic experiments 
show Drosophila Sirt2 is an important regulator of mitochon-
drial function and is the functional homologue of mammalian 
SIRT3. These experiments also provide a comprehensive view 
of the impact of acetylation on OXPHOS and its regulation by 
dSirt2. We demonstrate that ATP synthase , the catalytic 
subunit of complex V, is an acetylated protein, and it is a sub-
strate of Drosophila Sirt2 and human SIRT3.
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Figure 1. Increase in ceramide levels results in depletion of NAD+ and decrease in sirtuin activity leading to hyperacetylation of proteins in different cellular 
compartments. (A) dcerk1 fly extracts show 65% reduction in NAD+ level compared with w1118 control. n = 3. (B) NAD synthesis and salvage pathways. 
TDO, tryptophan-2,3-dioxygenase; KMO, kynurenine 3-monooxygenase; QPRTase, quinolinate phosphoribosyltransferase; NaMNAT, nicotinic acid mono-
nucleotide adenyltransferase; NADS, NAD synthetase; NMNAT, nicotinamide mononucleotide adenyltransferase; NAmPRTase, nicotinamide phosphoribo-
syl transferase; NDase, nicotinamidase; NaPRTase, nicotinic acid phosphoribosyltransferase. (C) Mass spectrometric measurements of metabolites in the 
salvage and the de novo pathways for synthesis of NAD+. n = 3. (D) Soluble, mitochondrial, and nuclear extracts were prepared from w1118 and dcerk1 
mutant flies and separated by PAGE. Protein acetylation was monitored by Western blotting using an anti–acetyl-Lys antibody. The individual blots were 
probed with antibodies to actin, porin, and H2A as loading controls. dcerk1 mutants show protein hyperacetylation in the different cellular compartments. 
Arrows indicate proteins that are hyperacetylated in dcerk1 compared with w1118. MM, molecular mass. (E) Mitochondrial NAD+ levels are decreased 
in dcerk1 compared with control. (F) d14 long chain base ceramides with different fatty acids were estimated by MS in sphingolipid-enriched fractions 
prepared from w1118 and dcerk1 mitochondria. C denotes the carbon chain length of fatty acids in the different ceramides. The amount of ceramide is nor-
malized to total carbon content, and the level in w1118 is taken as 100%. Many ceramides show significant increase in the mutant mitochondria compared 
with w1118. n = 3. Error bars represent SDs. *, P ≤ 0.05–0.01; **, P ≤ 0.01–0.001; ***, P ≤ 0.001–0.0001 in Student’s t test.
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Figure 2. dcerk1 mutants show acetylation of many OXPHOS subunits and decrease in complex V activity, which is rescued by supplementing NAD+ and 
inhibited by nicotinamide. dSirt2 regulates complex V activity in dcerk1 mutants. (A) BN-PAGE–separated bands from dcerk1 were digested with trypsin 
and subjected to LC-MS/MS to identify the different subunits of the complexes and the subunits that are acetylated. (B) dcerk1 mitochondria show a 40% 
reduction in complex V activity. Supplementing with NAD+ restores complex V activity in dcerk1. Complex V activity was normalized to the activity of 
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citrate synthase, a mitochondrial marker. The ATPase activity of untreated w1118 was taken as 100%. (C) Nicotinamide treatment further inhibits complex V 
activity in dcerk1. The ATPase activity of untreated w1118 was taken as 100%. n = 3. (D) Mitochondria were isolated from different sirtuin-null mutants, and 
complex V activity was measured. Complex V activity was normalized to the activity of citrate synthase. The ATPase activity of w1118 was taken as 100%. 
dsirt2 mutants show 30% reduction in activity. n = 3. (E) Mitochondria were isolated from w1118, dcerk1, dsirt2, dcerk1.dsirt2, and dcerk1.dsirt2 raised 
on food supplemented with NAD+, and complex V activity was measured. The ATPase activity of w1118 was taken as 100%. dcerk1.dsirt2 mutants show 
a further reduction in complex V activity compared with the single mutants. Supplementing with NAD+ does not alter this activity. n = 3. (F) The wild-type 
Sirt2 transgene was ubiquitously overexpressed using the actin-GAL4 driver in dsirt2 and dcerk1 mutants. The UAS-Sirt2 transgenic and GAL4 driver in 
each genetic background were additional controls. Mitochondria were prepared, and complex V activity was measured. The activity of w1118 was taken 
as 100%. Overexpression of the Sirt2 transgene significantly rescues complex V activity in the dsirt2 mutant and partially in the dcerk1 mutant. Error bars 
represent SDs. *, P ≤ 0.05–0.01; ** P ≤ 0.01–0.001; *** P ≤ 0.001–0.0001 in Student’s t test.
 
in tryptophan metabolism in an attempt to maintain NAD+ lev-
els. These results suggest a connection between ceramide and 
NAD metabolism.
One of the main NAD+-consuming pathways involves sir-
tuins because they are NAD+-dependent enzymes, and the avail-
ability of NAD+ is an important mechanism that regulates their 
activity (Imai et al., 2000). dcerk1 had greater decreases in NAD+ 
levels compared with those in cdase1; therefore, we investigated 
this mutant in more detail. As a readout for sirtuin activity in 
dcerk1, we compared the acetylation status of proteins in extracts 
prepared from different cellular compartments by western analy-
sis using a pan–acetyl-Lys antibody. Fig. 1 D shows that protein 
acetylation is increased in soluble, nuclear, and mitochondrial 
extracts of dcerk1 compared with those in control extracts, sug-
gesting a likely decrease in sirtuin deacetylase activity in dcerk1. 
We decided to focus on the mitochondrial compartment because 
dcerk1 exhibits phenotypes associated with mitochondrial dys-
function. These include decreased OXPHOS and decreased 
mitochondrial ATP level (Nirala et al., 2013). To test whether 
NAD+ level is altered in the mitochondria, we estimated its level 
in mitochondria isolated from w1118 and dcerk1 flies. Indeed, 
the mitochondrial NAD+ level is decreased in dcerk1 (Fig. 1 E). 
We estimated different ceramides by MS in purified mitochon-
dria isolated from dcerk1 and w1118 to test whether ceramide lev-
els are increased in mutant mitochondria (Dasgupta et al., 2009). 
Many ceramides show significantly increased levels in dcerk1 
mitochondria compared with those in the control (Fig. 1 F). The 
experiments described in the following sections probe the cor-
relation between dcerk1, sirtuin function, the acetylation of mi-
tochondrial proteins, and its impact on mitochondrial function.
Several OXPHOS proteins including  
those of complex V are acetylated in  
dcerk1 mutants
To investigate the increase in mitochondrial Lys acetylation ob-
served in dcerk1, we decided to focus on OXPHOS because it 
plays a central role in mitochondrial function. We prepared mi-
tochondria from control and dcerk1 flies and resolved individual 
OXPHOS complexes by blue native (BN) PAGE (Fig. S2 A). 
BN-PAGE allows for separation of complexes in their native 
state, which enables assessment of both the amount and activity 
of complexes (Wittig et al., 2006). We confirmed the identity 
of each complex by in-gel activity staining. As seen from the 
Coomassie-stained gel, the amount of complexes is not differ-
ent in control and mutant mitochondria, whereas activity stain-
ing suggested that activities of complexes II, III, IV, and V were 
reduced in dcerk1 mutant flies. Each band (other than complex 
I, which could not be isolated in sufficient amounts to identify a 
majority of its 50 subunits) was subjected to proteolytic diges-
tion and analyzed by liquid chromatography (LC)–MS/MS. The 
proteins identified in each complex in dcerk1 and those that are 
acetylated are shown in Fig. 2 A. Acetylated proteins were iden-
tified in each of the four complexes, suggesting that it could be 
a prevalent modification among OXPHOS proteins. Of the four 
complexes, we chose complex V for detailed analyses because it 
showed the largest number of acetylated proteins and because it 
directly controls ATP synthesis and hydrolysis, thereby strongly 
influencing cellular ATP levels.
Drosophila sirt2 mutants regulate  
complex V activity
Complex V catalyzes both ATP synthesis and ATP hydrolysis 
coupled with transmembrane proton translocation in mitochon-
dria (Boyer, 1997). The enzyme has two moieties—the water-
soluble F1 portion, which contains the catalytic sites for ATP 
generation and hydrolysis, and the membrane-integrated F0 
portion, which mediates proton translocation (Abrahams et al., 
1994; Noji et al., 1997). The enzymatic complex consists of a 
catalytic headpiece (33) that contains the three catalytic sites 
for ATP synthesis (one in each  subunit), a proton channel 
(ac8) and two stalks, the central rotor (, , and ), and the pe-
ripheral stator (bdF6OSCP).
dcerk1 mutants display a 40% decrease in complex V 
ATPase activity compared with that of control (Fig. 2, B and C). 
Because this decrease in activity was accompanied by de-
creased NAD+ and increased acetylation of complex V sub-
units, we tested whether we could rescue complex V activity 
in dcerk1 by supplementing with NAD+. We raised dcerk1 flies 
for a short period of time in food supplemented with NAD+ 
and measured complex V activity. Supplementing with NAD+ 
rescues the ATPase activity in dcerk1 (Fig. 2 B). Supplement-
ing high concentrations of nicotinamide, an inhibitor of sirtuin, 
further decreases complex V activity in the mutants (Fig. 2 C). 
We estimated NAD+ and nicotinamide levels in wild-type flies 
supplemented with a high concentration of nicotinamide in the 
food. Although there is a very modest increase in NAD+ level, 
there is a substantial increase in nicotinamide in the fed flies as 
a result of feeding pharmacological amount of nicotinamide in 
these flies (Fig. S2 B). These results show that complex V activ-
ity can be modulated by activation of a sirtuin with NAD+ or 
inhibition of a sirtuin with nicotinamide.
To test whether any of the five Drosophila sirtuins could 
regulate complex V, we measured ATPase activity of the com-
plex in mitochondria prepared from sir2-, sirt2-, sirt4-, and 
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sirt2 mutant results in a significant increase in complex V activ-
ity (Fig. 2 F). Overexpression of wild-type Sirt2 in the dcerk1 
mutant results in partial rescue. Overexpressed Sirt2 could com-
pete for the limited NAD+ in dcerk1 and result in better deacety-
lation of its substrates, including complex V, thereby leading to 
partial rescue (Fig. 2 F).
We also measured the ATP synthase activity in dcerk1 
and dsirt2 single and dcerk1.dsirt2 double mutant flies. In in-
tact mitochondria, the amount of oxygen consumption reflects 
the amount of ATP synthesis, and inhibition of ATP synthase or 
other OXPHOS complexes can cause a decrease in oxygen con-
sumption. We measured state 3 respiration (in the presence of 
added ADP) in freshly isolated mitochondria from the different 
flies. The dcerk1 and dsirt2 mitochondria displayed decreased 
sirt7-null mutants (Xie and Golic, 2004). Because Sirt6-null 
mutants are not available, Sirt6 knockdown flies were used, and 
this did not result in a significant reduction of complex V activ-
ity (unpublished data). Fig. 2 D shows that sirt2 mutant mito-
chondria display 30% reduction in ATPase activity compared 
with control. We then generated dcerk1.dsirt2 double mutants 
and assessed complex V activity. As seen in Fig. 2 E, there is a 
further reduction in complex V activity of dcerk1 in the absence 
of sirt2. Furthermore, feeding NAD+ does not rescue complex V 
activity of dcerk1 mutants in the absence of sirt2 (Fig. 2 E). 
In addition, the double mutants are semilethal, whereas individ-
ual mutants are viable, supporting a genetic interaction between 
these two mutants. Ubiquitous overexpression of a wild-type 
copy of the Sirt2 transgene (using the actin-Gal4 driver) in the 
Figure 3. Loss of sirt2 further reduces oxygen consumption and ATP levels and further increases mitochondrial protein acetylation in dcerk1 mutants. 
(A) Oxygen consumption was measured in freshly isolated mitochondria after addition of ADP (state 3 respiration). It is decreased in both dcerk1 and dsirt2 
mutant mitochondria compared with w1118. The double mutants show a further decrease in oxygen consumption. (B) ATP level is measured in w1118, dcerk1, 
sirt2, and dcerk1.dsirt2 fly mitochondria. The amount of ATP is calculated per milligram of mitochondrial protein and normalized to w1118. The relative 
level of ATP in individual dcerk1 and sirt2 is 60%, and the double mutant is 35% of w1118. (A and B) n = 3; error bars represent SDs. **, P ≤ 0.01–0.001; 
***, P ≤ 0.001–0.0001 in Student’s t test. (C) Mitochondrial extracts were prepared from w1118, dcerk1, sirt2, and dcerk1.dsirt2 flies and separated by 
PAGE followed by Western blotting using an anti–acetyl-Lys antibody. The blot was probed with an antibody to porin as a loading control. dcerk1.dsirt2 
double mutants show a further increase in protein acetylation compared with individual mutants. (D) Wild type and dsirt2 are subjected to starvation and 
the number of surviving flies is recorded at 6-h intervals. 200 flies divided into 10 groups for each genotype are used in one experiment. The representative 
graph shows the percentage of survival for each time interval.
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sites detected per mitochondrial protein shows that 43% of the 
proteins have one identifiable site, whereas the remainder have 
two or more sites, which suggests multiple points of regulation 
for a given protein (Fig. 4 B).
To gain insight into the biological functions of the acety-
lated proteins, we performed a pathway enrichment analysis 
of the mitochondrial acetylated proteins. Fig. 4 C shows that 
there is significant enrichment of proteins involved in the re-
spiratory electron transport chain and enzymes involved in py-
ruvate metabolism, TCA cycle, and amino acid metabolism. 
Other pathways identified include -oxidation of fatty acids, 
branched-chain amino acid catabolism, ketone body metabo-
lism, and antioxidant metabolism. In addition, our study identi-
fies acetylated proteins in Lys catabolism (lysine ketoglutarate 
reductase), -oxidation of pristanoyl CoA (pristanoyl CoA 
oxidase), and  fatty acid metabolism. To visualize probable 
consensus patterns around the acetyl-Lys sites, we compared 
the amino acid sequences of all acetylated sites using iceLogo 
(Colaert, et al., 2009). A preference for Leu or Tyr is observed 
at the +1 position, and a preference for Asp is observed at the 
1 and 3 positions, whereas positively charged residues are 
excluded at these positions (Fig. 4 D).
Analysis of the dSirt2-regulated  
acetylome identifies substrates in 
OXPHOS and metabolic pathways
A comparison of the wild-type Drosophila mitochondrial acety-
lome to that of dsirt2 mitochondria identifies that 204 acetylation 
sites in 116 proteins increased >1.5-fold in the mutant (Table S2). 
The GO cellular component analysis showed a significant enrich-
ment of mitochondrial terms (Fig. 4 E). Pathways enriched in the 
dsirt2 mutant included TCA cycle, amino acid metabolism, and 
electron transport chain (Fig. 4 F). Previously validated sub-
strates of mouse Sirt3, such as succinate dehydrogenase A, isoci-
trate dehydrogenase 2, and long chain acyl-CoA dehydrogenase, 
are identified in our study. These results suggest that Drosophila 
Sirt2 could serve as the functional homologue of mammalian 
SIRT3. In addition, mammalian SIRT3 shows highest homology 
(50% identity and 64% similarity) to Drosophila Sirt2.
Analyses of flanking sequence preferences in acetylated 
proteins that are increased in dsirt2 suggest a preference for Arg 
at the +1 site and exclusion of positive charge at the 1 posi-
tion (Fig. 4 G). The molecular function and biological process 
components of GO reveal significant enrichment of different 
complexes of the electron transport chain, with complex I being 
most significant followed by complex V in the wild-type mito-
chondrial acetylome (Fig. 5 A). The distribution of acetyl-Lys 
sites among the electron transport chain complexes suggests that 
30% of the acetylated subunits have one Lys site, whereas 70% 
have more than one site (Fig. 5 B). GO shows that both complex I 
and complex V feature prominently in the Sirt2 mutant acety-
lome (Fig. 5 C). Fig. 5 D shows a list of complex V subunits with 
site-specific acetyl-Lys identified earlier in dcerk1 and those that 
change 1.5-fold or more in dsirt2. To understand how complex V 
activity could be influenced by reversible acetylation, we fo-
cused on ATP synthase , as it is the catalytic subunit of the 
complex. We performed subsequent experiments in mammalian 
oxygen consumption and decreased ADP responsiveness com-
pared with that in control, suggesting that the rate of ATP syn-
thesis via OXPHOS was lower in the mutants compared with 
that in the control (Fig. 3 A). Absence of sirt2 further decreases 
the rate in dcerk1 as observed in dcerk1.dsirt2 double mutant flies 
(Fig. 3 A). We measured the ATP level in mitochondria isolated 
from w1118, dcerk1, and dsirt2 single mutants and dcerk1.dsirt2 
double mutants. Indeed, dcerk1 and dsirt2 show a 40% reduc-
tion in ATP levels compared with w1118, whereas there is a fur-
ther decrease in the double mutants (Fig. 3 B). These results 
suggest that Drosophila Sirt2 is a primary regulator of complex 
V activity in the dcerk1 mutant. Because absence of Sirt2 exacer-
bates complex V activity and ATP level of dcerk1, we also tested 
whether loss of Sirt2 would further increase the acetylation of 
mitochondrial proteins observed in dcerk1. Indeed, mitochon-
drial proteins from dcerk1.dsirt2 double mutants show in-
creased acetylation compared with the single mutants (Fig. 3 C). 
We then tested how dsirt2 mutant flies respond to conditions 
such as starvation stress, which increase ATP demand. dsirt2 
mutants succumb to starvation stress more rapidly than wild-
type flies (Fig. 3 D). The decreased ATP synthetic capacity in 
the mutants likely exacerbates the starvation survival response. 
dcerk1 mutants, however, do not show increased sensitivity to 
starvation because of AKT/FOXO-mediated up-regulation of 
novel triglyceride lipases (Nirala et al., 2013). A further indica-
tion of mitochondrial dysfunction in the dsirt2 mutant is the 
increased ROS level (Fig. S3).
Drosophila mitochondrial protein acetylome 
and dSirt2-regulated acetylome
To begin to understand how dSirt2 influences mitochondrial pro-
tein acetylation, we characterized the mitochondrial acetylome 
in wild-type and dsirt2 flies by quantitative MS. Previously, one 
proteome-wide mapping of the Drosophila acetylome has been 
performed from embryonically derived SL2 tissue-culture cells 
(Weinert et al., 2011). However, no proteomic investigations 
of either the total or mitochondrial acetylome have been per-
formed in flies. The strategy we used for identification of the 
Drosophila mitochondrial acetylome and the dSirt2-regulated 
acetylome is outlined in Fig. S4. We identified 1,178 unique 
acetyl-Lys sites in 530 proteins. Of these, 652 unique acetyl-Lys 
sites in 214 proteins were identified as mitochondrial using Fly-
Base and MitoDrome, a database of Drosophila nuclear genes 
coding for mitochondrial proteins (Table S1; Sardiello et al., 
2003). The identification of a large set of acetylated proteins 
enabled a systematic analysis of these proteins.
Pathway analysis of the Drosophila 
mitochondrial protein acetylome reveals 
widespread acetylation of OXPHOS 
proteins and other metabolic pathways
We performed functional annotation to determine the gene on-
tology (GO) terms associated with the acetylated proteins in 
wild-type control flies. The cellular component ontology, which 
describes protein location at the substructural level, shows 
a significant enrichment of mitochondrial-associated terms 
(Fig. 4 A). Analysis of the distribution of the number of acetyl-Lys 
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Figure 4. Analyses of the Drosophila mitochondrial acetylome and dSirt2 acetylome reveal extensive acetylation of proteins engaged in OXPHOS and 
metabolic pathways involved in energy production. (A) GO analysis (cellular component) of the acetylome shows significant enrichment of mitochondria-
related terms. (B) Distribution of acetyl-Lys sites identified per protein in the mitochondrial acetylome. (C) Pathway analysis of the mitochondrial acetylome 
with the number of proteins identified per pathway indicated. (D) Consensus sequence logo plot for acetylation sites, ±6 amino acids from all acetyl-Lys 
identified in the mitochondrial acetylome. (E) GO analysis (cellular component) of the acetylated proteins that increase in the dsirt2 mutant. (F) Pathway 
analysis of the acetylated proteins that increase in dsirt2 with the number of proteins identified per pathway indicated. (G) Consensus sequence logo plot 
for acetylation sites, ±6 amino acids from all acetyl-Lys identified in proteins that increase in dsirt2.
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human ATP synthase  or vector alone was transfected into 
HEK293T cells. After immunoprecipitation with the DDK tag 
antibody, acetylation level was determined by Western blot-
ting with the acetyl-Lys antibody. ATP synthase  is clearly an 
acetylated protein (Fig. 6 A). Based on our results from the ex-
periments in Drosophila described in the previous sections, we 
decided to test whether human SIRT3 can modulate the revers-
ible acetylation of ATP synthase . Knockdown of endogenous 
SIRT3 by siRNA increased the acetylation of ATP synthase 
cells to validate and extend our findings in a mammalian system. 
The mammalian experiments also benefited from the availabil-
ity of reagents and tools that are lacking in Drosophila.
Human ATP synthase  is an acetylated 
protein, and SIRT3 regulates its 
deacetylation and complex V activity
We evaluated whether mammalian ATP synthase  is an acet-
ylated protein. An expression vector encoding DDK-tagged 
Figure 5. Identification of complex V subunits 
with the Lys residues that are acetylated in dcerk1 
and dsirt2 mutants. (A) GO analysis (biological 
process component) of the Drosophila mitochon-
drial acetylome shows significant enrichment of 
OXPHOS complexes, particularly, complex I and 
complex V. The numbers indicate the number 
of acetylated subunits out of the total number of 
OXPHOS subunits in each complex. (B) Distribu-
tion of acetyl-Lys sites identified in each acetylated 
protein of the OXPHOS complexes shows 70% of 
the proteins have more than one site of acetyla-
tion. (C) GO analysis (biological process compo-
nent) of the acetylated proteins that increase in 
dsirt2 features OXPHOS complex I and complex V 
prominently. The numbers indicate the number 
of acetylated subunits out of the total number of 
OXPHOS subunits in each complex in the dsirt2 
mutant. (D) Mass spectrometric identification of 
the Lys residues that are acetylated in dcerk1 and 
dsirt2 (1.5-fold or more) in different subunits of 
complex V. For Lys residues that are conserved, 
the corresponding human Lys is shown. Asterisks 
denote Lys residues that have been identified as 
acetylated in other proteomic surveys. The blue 
numbers indicate modified Lys residues identified 
both in dcerk1 and dsirt2 mutants.
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that complex V activity correlates with the acetylation state of 
ATP synthase . These results are consistent with a model pro-
posing that SIRT3 regulates this process by deacetylating Lys 
259 and Lys 480.
To understand how these Lys residues could affect the cata-
lytic activity of ATP synthase , we examined the crystal struc-
ture of the bovine F1–stator complex in different conformational 
states: nucleotide free or bound to adenylyl imidodiphosphate, 
ADP, or ADP with the transition state mimetic aluminum 
fluoride (Abrahams et al., 1994; Menz et al., 2001; Rees et al., 
2009). Lys 259 (Lys 206, based on crystal structure labeling) 
identified in our study is located in a surface-exposed loop in all 
three states (Fig. 7 C). This loop connects to helix C, which fol-
lows the loop containing –Glu 188 and –Arg 189, and con-
tacts –Arg 373. All three residues are essential for catalysis 
(Menz et al., 2001). –Glu 188 directly interacts with the nu-
cleophilic water molecule that attacks the terminal phosphate of 
ATP during hydrolysis. –Arg 189 is involved in the direct 
binding of the  phosphate, and –Arg 373 in the  chain is a 
critical residue, termed an arginine finger, which contributes to 
catalysis by accelerating the rate of ATP cleavage by stabilizing 
the transition state of ATP hydrolysis. Thus, acetylation of Lys 
206 could potentially lead to conformational changes in the ac-
tive site region and affect the positioning of –Glu 188, –Arg 
189, and –Arg 373. Lys 480 (Lys 430 in the crystal structure), 
the second lysine identified in our study as a target for the Dro-
sophila Sirt2 deacetylase, is in a loop that packs over the base 
moiety of the nucleotide in the active site region in the nucleotide-
bound states. Notably, the backbone of Lys 430 mediates hydro-
gen bonding interactions with the backbone of Phe 418, which 
makes van der Waals contacts with the base. Lys 430 is involved 
in an intramolecular interaction with Glu 465. Acetylation of 
Lys 430 could disrupt this salt bridge interaction and potentially 
induce a conformational change in the nucleotide-binding re-
gion. These structural observations suggest that acetylation of 
Lys 259 and Lys 480 in ATP synthase  affects protein confor-
mation near the active site, thereby leading to decreased cata-
lytic activity.
Inverse correlation between acetylation of 
ATP synthase  and complex V activity in 
human cancer cell lines
We finally assessed the pathophysiological implications of acety-
lation of ATP synthase . The prevalence of acetyl modifications 
in mitochondrial proteins that affect energy metabolism suggests 
that altered acetylation could potentially contribute to diseases 
such as cancer and cardiac dysfunction, which exhibit recog-
nizable changes in energy metabolism. For these experiments, 
we chose three human breast cancer cell lines with different 
invasive potential: T47D, MDA-MB-435, and MDA-MB-231. 
T47D cells are more differentiated, weakly invasive, and rely 
less on aerobic glycolysis for energy compared with MDA-MB-
231 cells, which are less differentiated, strongly invasive, and 
have increased reliance on glycolysis for energy generation. 
We immunoprecipitated endogenous ATP synthase  from these 
cells and probed them with the acetyl-Lys antibody. ATP syn-
thase  is less acetylated in T47D cells compared with those of 
 (Fig. 6 B). Conversely, overexpression of SIRT3 leads to in-
creased deacetylation of ATP synthase  (Fig. 6 C). To ascer-
tain whether ATP synthase  is a specific target of SIRT3, we 
knocked down or overexpressed two other mitochondrial sirtu-
ins—SIRT4 and SIRT5. Knockdown of endogenous SIRT4 or 
SIRT5 by siRNA does not affect acetylation status of ATP syn-
thase  (Fig. 6, D and F). Overexpression of SIRT4 and SIRT5 
also does not affect acetylation of ATP synthase  (Fig. 6, 
E and G). Additionally, knockdown or overexpression of a nu-
clear sirtuin, SIRT1, also does not impact acetylation of ATP 
synthase  (Fig. 6, H and I). To determine whether the acety-
lation state of ATP synthase  altered complex V activity, we 
measured complex V activity in mitochondria prepared from 
cells treated with SIRT3 siRNA and scrambled siRNA. Knock-
down of SIRT3 results in 40% decrease in complex V activity 
(Fig. 6 J). We tested whether SIRT3 could directly interact with 
ATP synthase . We immunoprecipitated endogenous ATP syn-
thase  from HEK293T cells overexpressing SIRT3 and found 
that SIRT3 could coimmunoprecipitate with ATP synthase  
(Fig. 6 K). These results collectively suggest that mammalian 
SIRT3, like Drosophila Sirt2, can influence complex V activity 
by regulating the acetylation status of ATP synthase .
Conserved Lys residues in ATP synthase  
regulate complex V activity
We identified which Lys residues on ATP synthase  were im-
portant for regulating complex V activity. MS analysis of mito-
chondrial proteins shows that ATP synthase  is hyperacetylated 
at Lys 236 and Lys 457 in the absence of Drosophila Sirt2 (in 
dsirt2). Both these Lys residues were also identified in ATP syn-
thase  in dcerk1. The equivalent residues in human ATP syn-
thase  are Lys 259 and Lys 480. Before assessing the functional 
significance of these site-specific Lys residues, we down-regulated 
endogenous ATP synthase  level in HEK293T cells by siRNA 
to minimize any contribution from the endogenous protein. 
We generated an siRNA-resistant ATP synthase  construct by 
altering the codons without changing the amino acid residues 
in the siRNA target sequences. Fig. 7 A shows that robust ex-
pression of this construct is observed in the presence of siRNA 
compared with that of the nonresistant construct. We generated 
siRNA-resistant Lys 259 and Lys 480 mutants by changing the 
individual Lys to Arg or Gln. The Lys to Arg mutation is consid-
ered to mimic the deacetylated state, whereas the Lys to Gln 
mutation abolishes the positive charge and mimics the acetylated 
state (Schwer et al., 2006; Tao et al., 2010). Because of the lim-
ited amount of mitochondria obtained from the transfected cells, 
we used a commercially available assay for measuring complex 
V activity described in detail in the Materials and methods sec-
tion. Using this assay, we determined the activity of the Lys 259 
and Lys 480 variants. Fig. 7 B shows that K259R and K480R 
mutants have a 70–80% increase in activity, whereas K259Q 
and K480Q have an 40% decrease in activity compared with 
that of the control. We also generated double mutants that mimic 
the deacetylated state (K259/480R), which show a further in-
crease (150%) in activity, whereas double mutants that mimic 
the acetylated state (K259/480Q) show a 75–80% decrease in 
activity compared with that of the control. These results indicate 
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Figure 6. Human ATP synthase  is an acetylated protein, and its deacetylation is regulated by SIRT3. (A) pCMV vector or ATP synthase  (DDK tagged) 
was transfected in HEK293T cells, immunoprecipitated using an antibody to DDK tag, and probed with an antibody to acetyl-Lys (Ac-Lys). (B) HEK293T 
cells were cotransfected with ATP synthase  (ATP syn ) and either SIRT3 siRNA or scrambled siRNA. ATP synthase  was immunoprecipitated, and its 
acetylation status was assessed. The bottom blot shows reduction of SIRT3 protein upon siRNA treatment. Knockdown of SIRT3 increases acetylation of 
ATP synthase . (C) Expression vector for wild-type SIRT3 was cotransfected in HEK293T cells with ATP synthase , and its acetylation status was assessed 
after immunoprecipitation. Overexpression of SIRT3 decreases acetylation of ATP synthase . (D) HEK293T cells were cotransfected with ATP synthase  
and either SIRT4 siRNA or scrambled siRNA. SIRT4 knockdown does not affect acetylation of ATP synthase . (E) Wild-type SIRT4 expression vector was 
cotransfected in HEK293T cells with ATP synthase , and its acetylation status was assessed after immunoprecipitation. SIRT4 overexpression does not 
affect acetylation of ATP synthase . (F) HEK293T cells were cotransfected with ATP synthase  and either SIRT5 siRNA or scrambled siRNA. SIRT5 knock-
down does not affect acetylation of ATP synthase . (G) Wild-type SIRT5 expression vector was cotransfected in HEK293T cells with ATP synthase , and 
its acetylation status was assessed after immunoprecipitation. SIRT5 overexpression does not affect acetylation of ATP synthase . (H) HEK293T cells were 
cotransfected with ATP synthase  and either SIRT1 siRNA or scrambled siRNA. SIRT1 knockdown does not affect acetylation of ATP synthase . (I) Wild-
type SIRT1 expression vector was cotransfected in HEK293T cells with ATP synthase , and its acetylation status was assessed after immunoprecipitation. 
SIRT1 overexpression does not affect acetylation of ATP synthase . (J) Mitochondria were prepared from SIRT3 siRNA–treated or scrambled siRNA–treated 
cells, and complex V activity was measured. The activity of mitochondria from scrambled siRNA treatment was taken as 100%. SIRT3 knockdown results 
in an 40% decrease in complex V activity. n = 3; error bars represent SDs. **, P ≤ 0.01–0.001 in Student’s t test. (K) Endogenous ATP synthase  was 
immunoprecipitated from HEK293T cells overexpressing SIRT3, and the immunoprecipitate was probed with antibodies to ATP synthase  and SIRT3. SIRT3 
can coimmunoprecipitate with ATP synthase . IP, immunoprecipitation; WB, Western blot.
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Figure 7. Acetylation of ATP synthase  at Lys 259 and Lys 480 regulates complex V activity. (A) Nondegradable (non-deg) ATP synthase  (ATP syn 
) is resistant to targeted siRNA-mediated degradation. (B) siRNA-resistant versions of ATP synthase  wherein Lys 259 or Lys 480 either individually or 
together were substituted with Arg or Gln and cotransfected with siRNA to ATP synthase . Mitochondria were prepared, and complex V activity was 
measured using an immunocapture assay followed by the amount of ATP synthase  in the same samples. The activity of siRNA-resistant ATP synthase  
is taken as 100%. Substitution of either Lys or both with Arg results in increased activity, whereas substitution with Gln results in decreased complex V 
activity. **, P ≤ 0.01–0.001; ***, P ≤ 0.001–0.0001. (C) An overview of the crystal structure of bovine mitochondrial F1–stator complex is shown on 
the left in ribbon representation. The F1 domain contains 3 (green), 3 (purple), and a single subunit of  (pink). The stator complex shows portions of 
subunit b (teal), oligomycin sensitivity-conferring protein (orange), and F6 (yellowish green). The right shows a closer view of the region around the ac-
tive site (marked by the black box in the left image). The Lys residues are shown as spheres, and the active site amino acids are shown as stick models. 
Acetylation of Lys 259 (Lys 206 in the crystal structure) and Lys 480 (430 in the crystal structure) could affect protein conformation near the active site. 
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(D) Endogenous ATP synthase  was immunoprecipitated from human breast cancer cell lines, and its acetylation status was assessed using an acetyl-Lys 
antibody. ATP synthase  is more acetylated in MDA-MB-231 cells compared with T47D. (E) Complex V activity was measured in mitochondria prepared 
from human breast cancer cell lines. The activity is significantly less in MDA-MB-231 cells compared with that in T47D cells. n = 3. Analysis of variance 
was performed, and Tukey’s honest significance test was applied to determine significance. T47D–MDA-MB-231: adjusted P = 1.0 × 107; T47D–MDA-
MB-435: adjusted P = 1.9 × 105. (F) Oxygen consumption is less in MDA-MB-231 compared with that in T47D mitochondria. n = 3. Analysis of variance 
was performed, and Tukey’s honest significance test was applied to determine significance. T47D–MDA-MB-231: adjusted P = 2.0 × 106; T47D–MDA-
MB-435: adjusted P = 1.0 × 105. (G) A model depicting Drosophila Sirt2/mammalian SIRT3-mediated deacetylation of ATP synthase  and its impact on 
complex V activity. Error bars represent SDs. IP, immunoprecipitation; WB, Western blot.
 
MDA-MB-435 and MDA-MB-231 cells, which show the most 
acetylation (Fig. 7 D). We prepared mitochondria from these 
cells and measured complex V activity and oxygen consump-
tion rates. Complex V is more active in T47D cells compared 
with those of MDA-MB-435 and MDA-MB-231 cells (Fig. 7 E). 
T47D cells also show a higher oxygen consumption rate than 
MDA-MB-231 (Fig. 7 F). There appears to be an inverse cor-
relation between acetylation of ATP synthase  and complex 
V activity in these cell lines.
Discussion
In this study, we demonstrate that ATP synthase  is an acety-
lated protein, and its deacetylation is regulated by Drosophila 
Sirt2/mammalian SIRT3. Deacetylation of Lys 259 and Lys 480 
leads to increased enzyme activity of complex V. The activity of 
complex V is reduced when ATP synthase  is hyperacetylated, 
which occurs in Drosophila sirt2 mutants or in a human cell 
line when SIRT3 expression is reduced. We demonstrate that a 
novel ceramide–NAD+–sirtuin axis exists by linking increased 
ceramide levels to altered NAD+ levels and sirtuin activity in 
dcerk1 mutants. These results are summarized in the model de-
picted in Fig. 7 G. During the course of this study, we identified 
the Drosophila mitochondrial acetylome and determined poten-
tial substrates for dSirt2.
Although sphingolipids been extensively studied, a con-
nection between enzymes and metabolites of this pathway and 
protein acetylation/deacetylation or the effects of sphingolipids 
on NAD+ metabolism and sirtuins are largely unexplored. Our 
observations in dcerk1 mutants set the stage to further explore 
the sphingolipid–NAD–sirtuin axis and delineate links between 
sphingolipid metabolites and NAD metabolism. Although the 
reason for depletion of NAD+ is not clear, the increased glycoly-
sis and decreased OXPHOS observed in dcerk1 would accentu-
ate this decrease. NAD+ has been proposed as an attractive 
target in the management of various pathologies, particularly in 
the prevention of aging and related disorders, such as diabetes, 
obesity, and cancer (Yoshino et al., 2011; Houtkooper and Au-
werx, 2012). Many sphingolipids, including ceramide, are altered 
in obesity, diabetes, and aging (Russo et al., 2013). Further stud-
ies should help us decipher whether changes in the sphingolipid–
NAD axis contribute to stress-associated pathologies observed 
in these conditions.
Recent global proteomic surveys involving mitochondrial 
acetylation have focused on liver tissue from wild-type and 
Sirt3/ mice and embryonic fibroblasts derived from these 
mice (Sol et al., 2012; Hebert et al., 2013; Rardin et al., 2013). 
Our proteomic study using mitochondria from wild-type and 
dsirt2 flies provides the first inventory of acetylated proteins 
and sites in Drosophila mitochondria. In addition to comple-
menting the mouse studies, the availability of the Drosophila 
data will enable the use of the Drosophila model for evalua-
tion of several site-specific Lys variants in different proteins. 
It will facilitate studies of tissue-specific expression of consti-
tutively acetylated or deacetylated mutants, and the phenotypic 
consequences observed in these studies would lead to an un-
derstanding of the role of site-specific modifications in vivo. 
Enzymes involved in the TCA cycle, OXPHOS, -oxidation of 
fatty acids, and branched-chain amino acid catabolism, which 
are enriched in the mouse acetylome, are also enriched in the 
Drosophila acetylome. These results indicate a high degree of 
conservation of mitochondrial acetylation. Analyses of the sirt2 
acetylome reveal that many proteins that are hyperacetylated in 
dsirt2 mutants are also hyperacetylated in liver from Sirt3/ 
mice, and some of these candidates have been validated as sub-
strates of SIRT3. These results along with phenotypes, related to 
mitochondrial dysfunction, observed in the dsirt2 mutants (in-
creased ROS levels, decreased oxygen consumption, decreased 
ATP level, and increased sensitivity to starvation) strengthen the 
idea that dSirt2 serves as a functional homologue of mamma-
lian SIRT3. For any organism, tight regulation of ATP synthase 
activity is crucial to meet physiological energy demands in 
quickly changing nutritional or environmental conditions. Sir-
tuins regulate reversible acetylation under stress conditions. It is 
conceivable that acetylation-mediated regulation of complex V 
could constitute part of an elaborate control system.
Cancer cells generate a greater proportion of ATP via 
glycolysis instead of OXPHOS, a phenomenon called the 
Warburg effect (Warburg, 1956). Recent studies show that SIRT3 
dysfunction could be an important factor in this metabolic re-
programming (Kim et al., 2010; Finley et al., 2011a). Thus, 
alterations in mitochondrial acetylation states could contribute 
to the preference for aerobic glycolysis observed in cancer. 
Our results with human breast cancer cell lines show that ATP 
synthase  is more acetylated in MDA-MB-231 cells (which 
are less differentiated, strongly invasive, and more glycolytic) 
compared with that in T47D cells (which are more differen-
tiated, less invasive, and less reliant on aerobic glycolysis). 
It would be interesting to address whether the acetylation status 
of ATP synthase  could contribute to the pathological shift 
in energy generation observed in cancer cells. In conclusion, 
our study has identified a ceramide–NAD+–sirtuin connection 
in Drosophila and has shown that deacetylation of the ATP 
synthase  subunit mediated by Drosophila Sirt2/mammalian 
SIRT3 adds a new layer of regulation of mitochondrial com-
plex V activity.
 o
n
 August 25, 2014
jcb.rupress.org
D
ow
nloaded from
 
Published July 14, 2014
JCB • VOLUME 206 • NUMBER 2 • 2014 302
BN-PAGE
Mitochondria were prepared from flies in the presence of 10 mM nicotin-
amide and 500 nM trichostatin A and resuspended in buffer containing 
20 mM Bis-Tris, pH 7.0, 50 mM NaCl, 2 mM 6-aminohexanoic acid, and 
1 mM EDTA. 400 µg mitochondria was solubilized by adding 20% digi-
tonin corresponding to digitonin/protein ratios ranging from 4 to 6 g/g. 
The samples were incubated for 30 min at 4°C and then centrifuged for 
20 min at 16,000 g. The supernatant was separated by BN-PAGE at room 
temperature after addition of 5 µl of 50% glycerol and 3 µl Coomassie blue 
G-250 dye from a 5% suspension in 500 mM 6-aminohexanoic acid (Wittig 
et al., 2006). 4–12% gradient acrylamide gels were used for separation 
of the digitonin-solubilized respiratory complexes. The cathode buffer was 
50 mM tricine, 15 mM Bis-Tris, pH 7.0, and 0.02% Serva blue G-250 
(wt/vol), and the anode buffer was 50 mM Bis-Tris, pH 7.0. The gels were 
stained with Coomassie brilliant blue R-250 followed by destaining in a 
solution containing 10% methanol and 8% acetic acid, or in-gel activity 
assays were performed for mitochondrial protein complexes II–V.
In-gel activity staining of OXPHOS complexes was performed as fol-
lows: For complex II staining, the gel strip was incubated in 20 ml of 5-mM 
Tris-HCl, pH 7.4, containing 0.5 M sodium succinate, 215 mM phenazine 
methosulfate, and 20 mg nitrotetrazolium blue. Staining of complex III was 
achieved by incubating the gel strip in 50 ml complex III assay buffer con-
taining 50 mM potassium phosphate buffer, pH 7.4, and 20 mg DAB. 
After the color developed (6 h), the gel was scanned and then put back 
in the assay buffer, and 50 mg cytochrome c was added to start the com-
plex IV assay and stained for 1 h. For complex V staining, the gel strip 
was incubated overnight in a 50-ml solution containing 35 mM Tris-HCl, 
pH 8.0, 270 mM glycine, 14 mM MgSO4, 8 mM ATP, and 0.3% (wt/vol) 
Pb(NO3)2 with slow agitation. All steps were conducted at room tempera-
ture, and the reactions were stopped after the color was developed by fix-
ing the gel for 30 min in a solution containing 50% methanol (vol/vol) and 
10% acetic acid (vol/vol).
Sample preparation, MS, and data analysis
Bands corresponding to different OXPHOS complexes were excised from 
BN-PAGE gels and digested with trypsin. The peptides were desalted and 
subjected to LC-MS/MS using a mass spectrometer (LTQ Orbitrap Velos Pro 
with Proxeon Easy LC; Thermo Fisher Scientific), and the spectra were eval-
uated using SORCERER 2. For identification of the mitochondrial acety-
lome, mitochondria were prepared from w1118 flies in duplicate (3,000 
flies/batch). For identification of dsirt2 acetylome, mitochondria were pre-
pared similarly from dsirt2 mutant flies. The acetyl scans were performed 
at Cell Signaling Technology. Mitochondria were digested with trypsin, 
and acetyl-Lys peptide enrichment was performed using the acetyl-Lys motif 
antibody (#9895; Cell Signaling Technology). The LC-MS/MS analysis 
was performed using electrospray ionization–collision induced dissocia-
tion (LTQ Orbitrap Velos). The acetyl-Lys–enriched peptides were loaded 
directly onto a 10-cm × 75-µm capillary column (PicoFrit; New Objective) 
packed with reversed-phase resin (Magic C18 AQ; Michrom Bioresources). 
The column was developed with a 90-min linear gradient of acetonitrile in 
0.125% formic acid delivered at 280 nl/min.
MS parameter settings. The MS run time was 96 min, MS1 scan range 
was 300.00–1,500.00, and the top 20 MS/MS has a minimum signal of 
500. Isolation width was 2.0, normalized collision energy was 35.0, acti-
vation Q was 0.250, activation time was 20.0, and lock mass was 
371.101237. Charge state rejection parameter was enabled, and a charge 
state of 1+ was rejected. Dynamic exclusion was enabled, the repeat count 
was 1, repeat duration was 35.0, exclusion list size was 500, and exclu-
sion duration was 40.0. Exclusion mass width was relative to mass, and 
exclusion mass width was 10 ppm.
Informatics. MS/MS spectra were evaluated using SEQUEST 
3G and the SORCERER 2 platform obtained from Sage-N Research (v4.0; 
Lundgren et al., 2009). Searches were performed against the most recent 
update of the NCBI Drosophila database with a mass accuracy of ±50 
ppm for precursor ions and 1 D for product ions. Results were filtered with 
a mass accuracy of ±5 ppm on precursor ions and the presence of the in-
tended motif.
Bioinformatics
Enriched GO analysis and pathway analysis were performed using the 
ChIPpeakAnno package from Bioconductor (Zhu, et al., 2010). GO terms 
and pathways were annotated with at least five genes in the genome, and 
Benjamini and Hochberg–adjusted P < 0.01 was considered significantly 
enriched (Benjamini and Hochberg, 1995). Amino acid sequences were 
obtained using the biomaRt package obtained from Bioconductor (Durinck, 
Materials and methods
Fly stocks
Drosophila stocks were raised on standard corn meal agar and maintained 
at 25°C. dcerk1 is a severe hypomorphic allele generated by P element ex-
cision and characterized as previously described (Dasgupta et al., 2009). 
dsir2, sirt2, sirt4, and sirt7 mutant flies and the actin-GAL4 driver were ob-
tained from Bloomington Stock Center (Indiana University). The upstream 
activation sequence (UAS)–dSirt2 transgene was a gift from K. Chang (Uni-
versity of Southern California, Los Angeles, CA). The UAS RNAi line for 
dSirt6 was obtained from the Vienna Drosophila RNAi Center. dcerk1.dsirt2 
double mutants were generated by meiotic recombination, loss of ceramide 
kinase was confirmed by Western blotting, and absence of Sirt2 was con-
firmed by quantitative PCR. For rescue experiments, dcerk1 mutants were 
recombined to UAS-dSirt2 transgenic flies, and dsirt2 mutants were also 
recombined to UAS-dSirt2 transgenic flies.
Isolation of mitochondria
Approximately 1,000 flies were homogenized in mitochondrial isolation 
buffer containing 250 mM sucrose, 10 mM Tris, pH 7.4, and 0.15 mM 
MgCl2 with a pestle and mortar. The homogenate was centrifuged at 
4,000 g for 15 min at 4°C and then passed through an acrodisc syringe 
filter (0.45-µm pore size). The supernatant was centrifuged at 16,000 g for 
30 min to obtain a mitochondria-enriched pellet. The supernatant was re-
centrifuged at 16,000 g for 15 min, and the pellets were pooled, washed, 
and resuspended in isolation buffer for activity measurements. Mitochon-
drial enrichment was assessed by Western blotting the extract with an anti-
body to porin, a mitochondrial marker.
Assay of complex V (ATPase) activity
The assay relies on linking the ATPase activity to NADH oxidation via 
the conversion of phosphoenolpyruvate to pyruvate by pyruvate kinase 
and then pyruvate to lactate by lactate dehydrogenase. The reaction 
buffer consisted of 250 mM sucrose, 50 mM KCl, 5 mM MgCl2, 2 mM 
KCN, and 20 mM Tris-HCl, pH 7.5. Before the test, 0.25 mM NADH, 
1 mM phosphoenol pyruvate, 2.5 U/ml lactate dehydrogenase, and 
2 U/ml pyruvate kinase were added to the reaction buffer. The reaction 
was started by adding 40 µg Drosophila mitochondria, and the change 
in absorbance was recorded over 3 min at 340 nm. To determine the 
oligomycin-sensitive activity, the experiment was repeated with 6 µg/ml 
oligomycin. Complex V activity was calculated by using the extinction coef-
ficient 6.22 mM1cm1.
Metabolic profiling
For measurement of NAD+ and related metabolites, dcerk1 and w1118 (100 
flies each, in triplicate) were collected and frozen. The samples were pre-
pared and analyzed by LC-MS, LC-MS/MS, and gas chromatography–MS 
platforms by Metabolon.
Feeding experiments
For feeding experiments, 1-d-old w1118 or dcerk1 flies were transferred to 
fly food containing 50 mM nicotinamide or 10 mM NAD+. 1,000 flies 
were used (40 flies per vial) in each feeding experiment. After 24 h, the 
flies were transferred to vials containing fresh nicotinamide or NAD+. 
The flies were collected after 48 h, and mitochondria were prepared in 
the presence of nicotinamide or NAD+ and assayed for mitochondrial 
complex V activity.
Mitochondrial oxygen consumption
The rate of oxygen consumption was measured using a Clark-type elec-
trode. Freshly isolated mitochondria (0.5 mg/ml) were incubated in assay 
medium (120 mM KCl, 5 mM KH2PO4, 3 mM Hepes, 1 mM EGTA, 1 mM 
MgCl2, and 0.2% bovine serum albumin, pH 7.2) supplemented with a 
mixture of 20 mM sodium pyruvate and 20 mM proline as a substrate. 
State 3 rates were measured after the addition of 2 mM ADP.
Mitochondrial ROS production
The rate of mitochondrial H2O2 production was assayed fluorometrically 
by measuring the increase in fluorescence (excitation at 312 nm and emis-
sion at 420 nm) as a result of oxidation of homovanillic acid by H2O2 
in the presence of HRP. Freshly isolated mitochondria (0.2 mg/ml) were 
incubated in 2 ml assay medium containing 0.1 mM homovanillic acid and 
6 U/ml HRP. After a steady signal was obtained, substrate was added: 
either 5 mM pyruvate + 5 mM proline or 20 mM sn-glycerol 3-phosphate 
followed by 5 µM rotenone.
 o
n
 August 25, 2014
jcb.rupress.org
D
ow
nloaded from
 
Published July 14, 2014
303Sirtuin regulates ATP synthase  and complex V • Rahman et al.
relative specific activity of ATP synthase . The mitochondrial extract was 
solubilized with digitonin, and 40–60 µg was used per well. The plate was 
read using a microplate reader (Infinite M200 Pro; Tecan). Specific activity 
was taken as the ratio of complex V activity to quantity of ATP synthase  
in each well.
Structural observations of ATP synthase 
The structure of the F1–stator complex was generated with PyMOL (DeLano 
Scientific LLC) using the bovine F1–stator complex structure.
Preparation of soluble and nuclear extracts
Soluble extracts were prepared from w1118 and dcerk1 flies by washing 
them with buffer (50 mM Tris, pH 7.5, 1 mM EDTA, 2 mM -mercaptoethanol, 
50 mM KCl, 10 mM nicotinamide, and 500 nM trichostatin A) followed 
by homogenization in the same buffer. The homogenate was clari-
fied by a 15-min centrifugation at 12,000 g, and then, the supernatant 
was centrifuged at 150,000 g for 1 h at 4°C (Malcovati et al., 1973). 
For preparation of nuclear extracts, flies are ground in 10 mM Tris-Cl 
buffer, pH 8.0, containing 300 mM sucrose, 2 mM magnesium acetate, 
3 mM CaCl2, 0.1% Triton X-100, 0.5 mM DTT, 10 mM nicotinamide, 
and 500 nM trichostatin A. The homogenate is filtered through two sheets 
of 100-µm nylon mesh to remove large debris. Filtrates are transferred to 
a Teflon/glass homogenizer and stroked 40 times on ice. Homogenates 
are filtered through two sheets of 35-µm nylon mesh twice and then mixed 
with 10 mM Tris-Cl buffer, pH 8.0, containing 1.75 M sucrose, 5 mM 
magnesium acetate, 0.5 mm DTT, 10 mM nicotinamide, and 500 nM 
trichostatin. The mixture is then divided into two equal portions and is 
layered over a sucrose gradient consisting of 8 ml of 10-mM Tris-Cl buf-
fer, pH 8.0, containing 1.9 M sucrose, 5 mM magnesium acetate, and 
0.5 mM DTT over 4 ml of 10-mM Tris-Cl buffer, pH 8.0, containing 25% 
glycerol, 5 mM magnesium acetate, 5 mM DTT, 0.1 mM EDTA, 10 mM 
nicotinamide, and 500 nM trichostatin A in tubes of a rotor (SW 28; Beck-
man Coulter). The sample is then spun at 14,000 rpm for 15 min at 4°C. 
The supernatant is discarded, and residual supernatant is removed with 
a Kimwipe. Each pellet is resuspended in 500 µl of 10-mM Tris-Cl buffer, 
pH 8.0, containing 25% glycerol, 5 mM magnesium acetate, 5 mM DTT, 
0.1 mM EDTA, 10 mM nicotinamide, and 500 nM trichostatin A, and the 
suspension is spun for 1 min at maximum speed. Nuclei are recovered as 
a pellet (Hirayoshi and Lis, 1999).
Ceramide estimation
Sphingolipid-enriched fractions were prepared from mitochondria isolated 
from w1118 or dcerk1 flies. Mitochondria were homogenized in 2.0 ml 
methanol/chloroform (2:1) using a Teflon homogenizer in a glass tube fol-
lowed by 500 µl of water and vortexed. The homogenate was sonicated 
in a water bath–type sonicator for 20 min and incubated for 2 h at 37°C. 
To the extract, 1 ml of water and 500 µl chloroform were added, vortexed, 
and centrifuged at 1,000 rpm for 10 min at room temperature. The or-
ganic phase was collected and dried under nitrogen. Extracts were redis-
solved in 2 ml of synthetic upper (methanol/water/chloroform of 94:96:6) 
and applied to a pretreated column for solid-phase extraction (Sep-Pak 
C18; Waters Corporation). The column was washed with 4 ml of water, 
and lipids were extracted in 4 ml methanol followed by 4 ml methanol/
chloroform. The samples were dried under nitrogen and redissolved in the 
requisite amount of chloroform/methanol (1:1). The d14 sphingoid base 
containing ceramides was estimated by ultra-HPLC/MS (Dasgupta et al., 
2009, Yonamine et al., 2011).
Measurement of citrate synthase activity
Citrate synthase activity was measured by following the decrease in ab-
sorbance at 412 nm because of the reduction of DTNB (5, 5-dithiobis-(2-
nitro-benzoic acid)). The reaction mixture containing 0.1 M Tris-HCl, pH 
8.0, 0.3 mM acetyl-CoA, 0.1 mM DTNB, and 10 µg mitochondrial protein 
was incubated for 10 min. The reaction was initiated by adding 0.5 mM 
oxaloacetate, and the change in absorbance was monitored for 3 min. 
Citrate synthase activity was calculated by using an extinction coefficient 
of 13.6 mM1cm1.
Online supplemental material
Fig. S1 shows that the NAD+ level is decreased in the cdase1 mutant. 
Fig. S2 shows separation of OXPHOS complexes by BN-PAGE. Fig. S3 
depicts that dsirt2 and dcerk1 mutants show increased ROS levels. Fig. S4 
shows a strategy for identification of Drosophila mitochondrial acetylome 
and dSirt2-regulated acetylome. Table S1 shows details of acetyl-Lys pep-
tides in the mitochondrial acetylome identified by MS. Table S2 shows 
et al., 2005). Consensus amino acid patterns surrounding acetyl-Lys sites 
(±6 amino acids) were identified (P < 0.05) and visualized using iceLogo 
with nonacetylated lysines of all acetylated mitochondria proteins as the 
background model (Colaert, et al., 2009).
Cell culture and transfection experiments
Transfection was performed using the nucleofection device (Amaxa Nu-
cleofector; Lonza) and reagents according to the manufacturer’s standard 
protocol. In brief, HEK293T cells were cultured in DMEM (10% FBS + 1% 
penicillin-streptomycin) 3 d before the experiment. 5 × 105 cells were used 
for each nucleofection. The cell pellet was resuspended in 100 µl nucleo-
fection solution and then added to the total plasmid DNA (3 µg). The cell 
DNA mixture in a 1-cm cuvette is nucleoporated according to a predefined 
program (A-023). After electroporation, cells were incubated in media 
with 10 mM nicotinamide and 500 nM trichostatin A unless otherwise 
mentioned. Cells are harvested after 24 h for immunoprecipitation. DDK-
tagged (similar to FLAG tag) ATP synthase  (RC201638) and DDK-tagged 
human SIRT3 (RC200190), SIRT4 (RC212226), SIRT5 (RC200189), and 
SIRT1 (RC218134) plasmids were obtained from OriGene. In deacety-
lation experiments involving SIRT3 overexpression, DDK-tagged human 
SIRT3 was cotransfected with DDK-tagged ATP synthase , and cells were 
incubated in media without nicotinamide and trichostatin A. For siRNA ex-
periments, cells were transfected with each siRNA (1 µM) or the scrambled 
version, and cells were harvested after 72 h. The Trilencer siRNAs used to 
reduce SIRT3 (SR308255), SIRT4 (SR308254), SIRT5 (SR308253), SIRT1 
(SR308256), and the scrambled siRNAs were obtained from OriGene. 
The siRNA sequences used to reduce endogenous ATP synthase  were 5-
CUGCAUUAUUGGGCCGAAU-3 and 5-AAUCAACAAUGUCGCCAAA-
3 (Thermo Fisher Scientific).
Immunoprecipitation and immunoblotting
After transfection, cells were lysed in radioimmunoprecipitation assay buf-
fer with protease inhibitor cocktail (Roche). DDK-tagged proteins were im-
munoprecipitated using a DDK antibody (mouse), 4C5, coupled to protein 
G–agarose beads (OriGene). The immunoprecipitate was washed in ra-
dioimmunoprecipitation assay buffer and dissolved in SDS sample buffer. 
For immunoprecipitation of endogenous ATP synthase , either HEK293T 
or human breast cancer cells were lysed in NP1 buffer (PBS with 0.5% 
Nonidet P-40) and protease inhibitor cocktail. The extract is incubated for 
8–10 h at 4°C with an antibody to ATP synthase  (MitoSciences) or IgG 
(mock) followed by addition of immobilized protein G (Thermo Fisher Sci-
entific) and incubated further for 12 h at 4°C. The beads were centrifuged 
at 5,000 rpm for 5 min and washed three times in NP1 buffer. The beads 
were then incubated with 2× SDS sample buffer without -mercaptoethanol 
for 10 min at room temperature. The beads were centrifuged, and the su-
pernatant was separated by SDS-PAGE after addition of -mercaptoetha-
nol. For Western blotting, mouse anti-DDK antibody (OriGene) was used at 
1:2,000, mouse anti-ATP synthase  was used at 1:4,000 (MitoSciences), 
and rabbit anti–human SIRT3 antibody (Cell Signaling Technology) was 
used at 1:1,000. HRP-conjugated rabbit or mouse secondary antibodies 
(Jackson ImmunoResearch Laboratories, Inc.) were used at 1:5,000 dilu-
tion. For Western blot analysis, the rabbit anti–acetyl-Lys antibody (Cell 
Signaling Technology) was used at 1:500, and the HRP-conjugated rabbit 
secondary antibody was used at a 1:3,000 dilution. The blotting was per-
formed following a published protocol (Guan et al., 2010).
Plate assay for measuring complex V activity
An siRNA-resistant ATP synthase  was synthesized by making the follow-
ing changes to 5-TTGATTAATAACGTTGCA-3 (corresponding to amino 
sequence LINNVA) and 5-AGTGCTCTGCTCGGAAGG-3 (corresponding 
to amino acid sequence SALLGR). Either the nondegradable wild-type con-
struct or each of the nondegradable site-specific Lys substitutions was trans-
fected along with the siRNAs. Cells were harvested after 75 h, and 
mitochondrial-enriched fractions were prepared. The two-step complex V 
assay was performed using the ATP synthase-specific activity microplate 
assay kit according to the manufacturer’s instructions (MS543; MitoSci-
ences). In this assay, the F0F1-ATPase holoenzyme is immunocaptured 
within the wells of a 96-well microplate that is coated with an antibody that 
recognizes all subunits of the complex. The enzymatic hydrolysis of ATP to 
ADP is coupled to the oxidation of NADH to NAD+, which results in a de-
crease in absorbance at 340 nm. Subsequently, in the same wells, the 
quantity of ATP synthase  is determined by adding an ATP synthase  an-
tibody conjugated with alkaline phosphatase. An increase in absorbance 
at 405 nm is measured, and this is proportional to the amount of ATP syn-
thase  captured in the wells. The ratio of activity to quantity represents the 
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Figure S1.  MS measurements of NAD+ and metabolites involved in the salvage pathway and de novo synthesis of NAD+ from tryptophan in cdase1 mu-
tants NAD+ level is decreased in cdase1 mutants. The levels of nicotinamide riboside (in the salvage pathway) and 3-hydroxy kynurenine (synthesis from 
tryptophan) are increased. Extracts were prepared from 100 flies, and three replicates were performed. Error bars represent SDs, and statistical signifi-
cance was determined using Student’s t test; *, P ≤ 0.05–0.01; **, P ≤ 0.01–0.001; ***, P ≤ 0.001–0.0001.
Figure S2.  Separation of OXPHOS complexes by BN-PAGE. (A) Separation of mitochondrial OXPHOS complexes from w1118 and dcerk1 by BN-PAGE and 
their activity staining. (B) Mass spectrometric measurements of NAD+ and nicotinamide in w1118 flies fed nicotinamide. Error bars represent SDs, and statisti-
cal significance was determined using Student’s t test; **, P ≤ 0.01–0.001.
JCB S2 
Table S1 shows details of acetyl-Lys peptides in the mitochondrial acetylome identified by MS and is 
provided in an Excel file.
Table S2 shows details of acetyl-Lys peptides that increase in dsirt2 mutant mitochondrial acetylome 
identified by MS and is provided in an Excel file.
Figure S3.  dsirt2 mutant flies show increased ROS levels. Mitochondria were prepared from w1118, dcerk1, and dsirt2 mutants, and ROS production was 
measured using pyruvate + proline (left) or sn-glycerol 3-phosphate (right) as a substrate. ROS levels are increased in dcerk1 and dsirt2 compared with 
w1118 mitochondria. Mitochondria were prepared from 1,000 flies for each batch. n = 3; error bars represent SDs. Statistical significance was determined 
using Student’s t test: **, P ≤ 0.01–0.001; ***, P ≤ 0.001–0.0001.
Figure S4.  Strategy for identification of Drosophila mitochondrial acetylome and dSirt2-regulated acetylome. Mitochondria were isolated from 3,000 flies 
(w1118 or dsirt2) per batch. The mitochondrial extracts were digested with trypsin and desalted. Acetyl-Lys peptides were immunoprecipitated using an ace-
tyl-Lys antibody. The enriched peptides were separated by LC-MS/MS. The MS/MS spectra were evaluated using SEQUEST 3G and SORCERER 2 platform, 
and label-free quantitation was performed from the acetyl-Lys peptide intensities. The experiment was performed in duplicate.
